Paper33296145
Mechanisms of small cell lung cancer metastasis.
Ko J and 2 others. EMBO Mol Med, 2021. Cited by 178 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of small cell lung cancer metastasis. Papers, record 33296145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33296145
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Small Cell Lung Carcinoma | Major topic |
| Animals | |
| Cell Movement | |
| Humans | |
| Mice | |
| Neoplasm Metastasis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 CA231997 | NCI NIH HHS | United States | R35CA231997 | PubMed and NIH | NIH RePORTER |
| T32 CA009302 | NCI NIH HHS | United States | T32CA009302 | PubMed | NIH RePORTER |
References124
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15170136 | High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. | Am J Clin Oncol | 2004 | https://conductscience.org/library/papers/15170136 | PubMed |
| 2 | 31870883 | Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies. | J Thorac Oncol | 2020 | https://conductscience.org/library/papers/31870883 | PubMed |
| 3 | 27869802 | Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. | Nat Med | 2017 | https://conductscience.org/library/papers/27869802 | PubMed |
| 4 | 31412616 | Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer. | Cells | 2019 | https://conductscience.org/library/papers/31412616 | PubMed |
| 5 | 28429473 | Surgery for limited-stage small-cell lung cancer. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28429473 | PubMed |
| 6 | 22584211 | Pleural effusion in lung cancer: more questions than answers. | Respiration | 2012 | https://conductscience.org/library/papers/22584211 | PubMed |
| 7 | 10441603 | Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10441603 | PubMed |
| 8 | 25504108 | Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo. | Int J Mol Med | 2015 | https://conductscience.org/library/papers/25504108 | PubMed |
| 9 | 20406986 | Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. | Cancer Res | 2010 | https://conductscience.org/library/papers/20406986 | PubMed |
| 10 | 30181244 | Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. | Cancer Discov | 2018 | https://conductscience.org/library/papers/30181244 | PubMed |
| 11 | 27269741 | Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/27269741 | PubMed |
| 12 | 11591806 | A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. | J Immunol | 2001 | https://conductscience.org/library/papers/11591806 | PubMed |
| 13 | 17699816 | Prophylactic cranial irradiation in extensive small-cell lung cancer. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17699816 | PubMed |
| 14 | 27374332 | Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility. | Cell | 2016 | https://conductscience.org/library/papers/27374332 | PubMed |
| 15 | 20338593 | Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells. | J Surg Res | 2011 | https://conductscience.org/library/papers/20338593 | PubMed |
| 16 | 21678053 | Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer. | Mol Biol Rep | 2012 | https://conductscience.org/library/papers/21678053 | PubMed |
| 17 | 23011677 | Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment. | Clin Exp Metastasis | 2013 | https://conductscience.org/library/papers/23011677 | PubMed |
| 18 | 16909976 | Neurone-specific enolase and liver metastasis in small cell lung cancer. | Clin Oncol (R Coll Radiol) | 2006 | https://conductscience.org/library/papers/16909976 | PubMed |
| 19 | 24482365 | PTEN is a potent suppressor of small cell lung cancer. | Mol Cancer Res | 2014 | https://conductscience.org/library/papers/24482365 | PubMed |
| 20 | 26435104 | Formation of a Neurosensory Organ by Epithelial Cell Slithering. | Cell | 2015 | https://conductscience.org/library/papers/26435104 | PubMed |
Cited by131
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42840183 | The Five-Decade Journey of Small Cell Lung Cancer. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42840183 | PubMed |
| 42818943 | Quantitative dissection of the metastatic cascade at single colony resolution. | Res Sq | 2026 | https://conductscience.org/library/papers/42818943 | PubMed |
| 42738408 | Prognostic and Treatment-Context Associations of EASIX and IPI in Extensive-Stage Small-Cell Lung Cancer Patients Receiving First-Line Therapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738408 | PubMed |
| 42718760 | Radiographically occult bone marrow metastasis in relapsed small cell lung cancer presenting with rapidly progressive thrombocytopenia: a case report. | Front Oncol | 2026 | https://conductscience.org/library/papers/42718760 | PubMed |
| 42524036 | Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions. | Ther Adv Med Oncol | 2026 | https://conductscience.org/library/papers/42524036 | PubMed |
| 42518680 | EV-Mediated Oncogenic Regulation in Lung Cancer and Clinical Translation: From Liquid Biopsy to Targeted Delivery Systems. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42518680 | PubMed |
| 42461725 | ABL kinase inactivation induces transcription-replication conflicts and impairs replication fork progression in metastatic small cell lung cancer. | Cell Rep | 2026 | https://conductscience.org/library/papers/42461725 | PubMed |
| 42376249 | Recent advances in engineered nanozymes for precision lung cancer therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42376249 | PubMed |
| 42366270 | Navigating toxicity in lung cancer immunotherapy: challenges and advances in Nano medicine drug delivery. | J Egypt Natl Canc Inst | 2026 | https://conductscience.org/library/papers/42366270 | PubMed |
| 42124569 | Quantitative dissection of the metastatic cascade at single colony resolution. | bioRxiv | 2026 | https://conductscience.org/library/papers/42124569 | PubMed |
| 42104439 | Exosomal circPOLK promotes metastasis of NSCLC cells via regulating mir-1204/SOX8 axis. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42104439 | PubMed |
| 41937137 | Efficacy and safety of albumin-bound paclitaxel combined with simvastatin in the second-line treatment of small cell lung cancer: a phase II randomized controlled trial. | BMC Med | 2026 | https://conductscience.org/library/papers/41937137 | PubMed |
| 41574603 | EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy. | JCI Insight | 2026 | https://conductscience.org/library/papers/41574603 | PubMed |
| 41462172 | Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/41462172 | PubMed |
| 41411619 | Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments. | Cancer Res | 2026 | https://conductscience.org/library/papers/41411619 | PubMed |
| 41390896 | Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer. | Br J Cancer | 2026 | https://conductscience.org/library/papers/41390896 | PubMed |
| 41383468 | CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agent. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41383468 | PubMed |
| 41361170 | ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer. | Nat Commun | 2025 | https://conductscience.org/library/papers/41361170 | PubMed |
| 41326647 | Interpretable multiclassification machine learning models in predicting the extent of small cell lung cancer metastasis. | Sci Rep | 2025 | https://conductscience.org/library/papers/41326647 | PubMed |
| 41318700 | Advancing small cell lung cancer metastasis research: innovations in preclinical mouse models. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/41318700 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33296145
GET https://conductscience.org/api/papers/v1/33296145/references?page=2